Dietary supplement use and nosebleeds in hereditary haemorrhagic telangiectasia ‒ an observational study

DOI Web Site 参考文献26件
  • Chamali Basel
    National Heart and Lung Institute Cardiovascular Sciences, Imperial College London Imperial College School of Medicine, Imperial College London
  • Finnamore Helen
    National Heart and Lung Institute Cardiovascular Sciences, Imperial College London Diabetes and Nutritional Sciences Division, King’s College London
  • Manning Richard
    Haematology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust
  • Laffan Michael A
    Haematology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust Centre for Haematology, Imperial College London
  • Hickson Mary
    Nutrition and Dietetics, Imperial College Healthcare NHS Trust, London, UK (Current address: School of Health Professions, Plymouth University
  • Whelan Kevin
    Diabetes and Nutritional Sciences Division, King’s College London
  • Shovlin Claire L
    National Heart and Lung Institute Cardiovascular Sciences, Imperial College London HHTIC London, Hammersmith Hospital, Imperial College Healthcare NHS Trust

この論文をさがす

抄録

Understanding potential provocations of haemorrhage is important in a range of clinical settings, and particularly for people with abnormal vasculature. Patients with hereditary haemorrhagic telangiectasia (HHT) can report haemorrhage from nasal telangiectasia in real time, and suggested dietary factors may precipitate nosebleeds. To examine further, nosebleed severity, dietary supplement use, and blood indices were evaluated in an unselected group of 50 HHT patients recruited from a specialist UK service. Using the validated Epistaxis Severity Score, nosebleed severity ranged from 0 to 9.1 out of 10 (median 3.9). Using a Food Frequency Questionnaire, 24/50 (48%) participants reported use of dietary supplements in the previous year. A third (18/50; 36%) had used self prescribed, non-iron containing dietary supplements, ingesting between 1 and 3 different supplements each day. Eight (16%) used fish oils. Despite having more severe epistaxis (p = 0.012), the 12 iron supplement users had higher serum iron concentrations, and were able to maintain their red blood cell indices. In contrast, there was no evident benefit for the participants using non iron supplements. Furthermore, platelet counts and serum fibrinogen tended to be lower in fish oil/supplement users, and one fish oil user demonstrated reduced in vitro platelet aggregation. In conclusion, in this small study, a third of HHT patients used non-iron dietary supplements, and one in six ingested fish oils, unaware of their known anti-platelet activity. The scale of use, and potential of these "natural health supplements" to exacerbate nosebleeds has not been appreciated previously in HHT.

収録刊行物

  • Intractable & Rare Diseases Research

    Intractable & Rare Diseases Research 5 (2), 109-113, 2016

    特定非営利活動法人 バイオ＆ソーシャル・サイエンス推進国際研究交流会

参考文献 (26)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ